<DOC>
	<DOCNO>NCT00275158</DOCNO>
	<brief_summary>Pre-eclampsia complicates 7 - 10 % pregnancy constitute lead cause fetal growth retardation premature birth , well infant maternal morbidity mortality . The kidney primary site injury result high blood pressure , loss protein urine decrease kidney function . The release vasoconstrictor vasodilator abnormal placenta may underlie pre-eclampsia . Nitric Oxide ( NO ) important vasodilator think play important role kidney ability accommodate healthy pregnancy . Normal pregnancy rat accompany increase production NO second messenger cGMP . There parallel increase renal expression constitutive nitric oxide synthase ( NOS ) , enzyme generate NO arginine . In pregnant rat , infusion NG-nitro-L-arginine methyl ester ( L-NAME ) , exogenous inhibitor NOS , show replicate hemodynamic feature syndrome pre-eclampsia . In recent animal study , L-arginine supplementation reverse adverse effect L-NAME pregnancy attenuate high blood pressure significantly decrease protein loss urine . To date , study use L-arginine supplementation treat woman pre-eclampsia small uncontrolled assess blood pressure primary outcome measure . We report single center , randomize , placebo-controlled trial L-arginine supplementation treatment pre-eclampsia , precise physiological technique utilized assess kidney dysfunction addition blood pressure .</brief_summary>
	<brief_title>Glomerular Injury Preeclampsia</brief_title>
	<detailed_description>OBJECTIVE : To assess benefit L-arginine , precursor nitric oxide ( NO ) , blood pressure recovery glomerular lesion pre-eclampsia . METHODS : 45 woman pre-eclampsia randomized receive either L-arginine placebo day 10 post-partum . Primary outcome measure include MAP , glomerular filtration rate proteinuria assess third tenth day postpartum inulin clearance albumin-to-creatinine ( A/C ) ratio . NO , cyclic guanosine 3 ' 5 ' monophosphate ( cGMP ) , endothelin-1 ( ET ) asymmetric-dimethyl-arginine ( ADMA ) arginine level assay prior delivery , third tenth day postpartum . Healthy gravid woman provide control value . Assuming standard deviation 10 mmHg , study power detect 10 mmHg difference MAP ( alpha 0.05 , beta 0.20 ) study group . RESULTS : No significant difference exist group pre-eclampsia prior randomization . Compared gravid control group , woman pre-eclampsia reveal significantly depressed level serum arginine , reveal significantly increase serum level ET , cGMP ADMA prior delivery . Despite significant increase serum arginine level due treatment , difference find level NO , ET , cGMP ADMA two group pre-eclampsia . Further , significant difference primary outcome measure group demonstrate equivalent improvement blood pressure proteinuria . CONCLUSION : Blood pressure kidney function improve markedly pre-eclampsia tenth day postpartum . L-arginine supplementation hasten recovery .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<criteria>Women select study diagnose preeclampsia second half pregnancy . . ) elevation blood pressure level excess 140 systolic 90 diastolic ii . ) proteinuria determine urine dipstick value ≥ 2+ , quantitated ≥ 0.5 g either per gram creatinine 24 hour urine collection . Women history underlie renal disease define prepregnancy azotemia ( serum creatinine ≥ 1.2 mg/dl ) proteinuria</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Pre-Eclampsia</keyword>
	<keyword>Glomerular Filtration Rate ( GFR )</keyword>
	<keyword>Inulin clearance</keyword>
	<keyword>Hypertension</keyword>
	<keyword>L-Arginine</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>cGMP</keyword>
	<keyword>Endothelin</keyword>
	<keyword>ADMA</keyword>
</DOC>